| Identification | Back Directory | [Name]
Vibostolimab | [CAS]
2231305-30-7 | [Synonyms]
Vibostolimab
Vibostolimab (anti-TIGIT)
Research Grade Vibostolimab(DHH72403) |
| Hazard Information | Back Directory | [Uses]
Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research[1]. | [References]
[1] Niu J, et al. First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆. Ann Oncol. 2022 Feb;33(2):169-180. DOI:10.1016/j.annonc.2021.11.002 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 |
| Website: |
www.biolabreagent.com/ |
|